The Colorado Division of Insurance (DOI) has issued guidance regarding how firms collect and use information about an applicant relating to the opioid anti-overdose medication naloxone.
Officials said the guidance was issued in conjunction with the Department of Regulatory Agencies (DORA), noting Colorado law permits the purchase of naloxone by a family member, friend, or another person in a position to assist someone at risk of an opiate-related overdose.
The DOI said the expectation is insurers issuing life insurance, annuity contracts, sickness and accident insurance, or disability insurance will not deny an application, rescind coverage or charge an applicant more for insurance due to the applicant having received a naloxone prescription.
Additionally, the DOI maintains a person with a naloxone prescription is unlikely to self-administer the drug, indicating the prescription would only be for aiding a friend, family member or other person and declining insurance applications, rescinding coverage, or charging higher premiums for people who are trying to help others by reducing opioid overdoses would be a serious blow to the state’s public health efforts.
The DOI is asking anyone who believes they have been denied insurance or charged more due to a naloxone prescription to make contact with the agency’s dedicated Consumer Services team by calling 303-894-7490 / 800-930-3745 or visiting the DOI website.